Insider Transactions in Q4 2025 at Esperion Therapeutics, Inc. (ESPR)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 17
2025
|
Sheldon L. Koenig President and CEO |
SELL
Open market or private sale
|
Direct |
48,244
-3.18%
|
$144,732
$3.67 P/Share
|
|
Dec 17
2025
|
Benjamin Looker General Counsel |
SELL
Open market or private sale
|
Direct |
6,517
-1.66%
|
$19,551
$3.67 P/Share
|
|
Dec 17
2025
|
Benjamin Halladay Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,337
-1.55%
|
$22,011
$3.67 P/Share
|
|
Dec 04
2025
|
John B. Harlow Jr. Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
424,536
+50.0%
|
-
|
|
Oct 17
2025
|
Benjamin Looker General Counsel |
SELL
Open market or private sale
|
Direct |
1,248
-0.32%
|
$2,496
$2.62 P/Share
|